Woman in lab doing tests

Stepping Up Innovation

At Teva Pharmaceuticals, we are a different kind of biopharmaceutical company — innovating at every stage of drug development and delivery.

Teva research and development (R&D) is at the forefront of healthcare innovation. Our commitment to advancing medical science is evident through our strategic pillar of Stepping Up Innovation, which guides us as we work to enhance patient care and expand healthcare access.

From in-house innovation to strategic partnerships, we are persistent in the creation of innovative medicines, generics and biosimilars to increase the accessibility and affordability of existing medicines. 

Two scientists in lab coats and safety glasses use pipettes to transfer liquids into test tubes in a laboratory setting.

Our R&D Pipeline

At Teva, research and development is the backbone of our healthcare innovation. Explore our Innovative Medicine and Biosimilar Pipeline.

View Teva’s Product Pipeline Our R&D Pipeline

We believe the future of R&D is now, and we’re constantly seeking new innovations in healthcare. To support better health outcomes, we are innovating where it matters most by leveraging our stand-out capabilities, best-in-class antibody and device engineering, and advancing formulations expertise in our innovative and generic medicines. With proven capabilities in neuroscience, medicine research and expanding expertise in immunology, we continually conduct thoughtful drug development. 

An older woman with gray curly hair stands outdoors, eyes closed, with one hand on her chest and the other open in front of her, appearing calm and relaxed.

Innovative Therapeutic Areas in Focus

Teva is transforming patient care through our focus on cutting-edge therapeutic areas. Learn about our latest innovations and advancements in medicine.

Explore Teva’s Innovative Therapeutic Areas Innovative Therapeutic Areas in Focus

Pushing Innovation Boundaries

Our team is agile and curious, using deep scientific knowledge and diverse technologies to uncover rich pathways, spark unique connections, and make bold discoveries. We focus on cutting-edge technologies and scientific pathways to find scalable solutions. Continuous investment in breakthrough science allows us to identify more potential treatments, paving the way for better health outcomes for patients worldwide. 

A smiling nurse in scrubs with a stethoscope talks to a young girl and an adult in a clinic. The scene conveys warmth and care.

Teva Clinical Trials

Stay informed about Teva clinical research and how we contribute to the development of new drugs through rigorous testing.

Explore Teva Clinical Trials Teva Clinical Trials

Cultivating Collaboration

At Teva, solving problems means bringing the best minds together. Our cross-functional teams work seamlessly to bring discovery from pipeline to patient. We seek partners who share our vision and commitment to bringing new therapies to market faster.

Our extensive global network of research facilities and dedicated scientists support cutting-edge research and translate scientific discoveries into practical treatments. Ensuring our scientific breakthroughs reach those in need is at the core of our efforts.

Two doctors in white coats have a focused discussion at a table. One holds a pen, while the other gestures. A coffee cup sits nearby.

Explore Collaborative Research (CR) & Investigator Sponsored Studies (ISS) with Teva

Discover how Teva supports independent and joint research with healthcare partners around the globe, in an effort to bring new therapies to market and address important questions for patients, caregivers, healthcare providers and payers.

Discover more Explore Collaborative Research (CR) & Investigator Sponsored Studies (ISS) with Teva

By cultivating collaboration and operating across the full spectrum of innovation, we’re striving to transform healthcare and make a meaningful difference in patients’ lives. Together, our science can shape a brighter, healthier future for all. Together, we are all in for better health. 

NPS-ALL-NP-01528 APRIL 2025